🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Remote Temperature Monitoring of Patients At Risk for Developing Fever

RecruitingNAAges 18 Years - anyAllAION Biosystems
NCT06752512 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this program is to evaluate remote temperature monitoring in cancer patients at risk of fever and infection due to chemotherapy treatment. The main questions it aims to answer are: * does remote temperature monitoring reduce the number of days spent inpatient * what out-of-pocket cost can a patient expect to incur for participating in remote temperature monitoring * the number of billable CPT codes that will be generated by providing remote temperature monitoring Researchers will compare compliant and non-compliant patients to assess if compliance with remote temperature monitoring is associated with a decrease in the number of days spent inpatient. Patients will * wear the thermometer for the duration of their participation in the study * have their temperature monitored continuously * receive alerts on their phone when their temperature exceeds a threshold for a sust

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Subject is at risk of a fever post discharge. * Subject is ≥ 18 years or older. * Subject has an iOS or Android phone, or is able to operate an AION provided smartphone device. * Subject is willing to install the TempShield app on his/her phone. * Subject is willing to allow AION to send text reminders to take temperature or complete surveys. * Subject is willing to take an oral temperature as directed by their care plan. * Subject is willing to configure the phone to ensure these notifications are delivered, even when phone is in a "no notification" mode. * Subject or subject caretaker is able and willing to complete subject surveys. * Subject is willing and able to provide written informed consent in English. * Subject is willing and able to comply with all program procedures, requirements, assessments, visits, and complete questionnaires. * English speakers Exclusion Criteria: * Unable to provide informed consent * Subjects with a history of Medical Adhesive-Related Skin Injury (MARSI) * Subjects with no available placement that avoids open wounds or traumatized skin (burns. Blisters. Etc.) * Non-English speakers: The mobile application is only currently available in English. Future development will include other languages. * Subjects receiving prophylactics that could induce fever. * Subjects with a silicon allergy * Subject does not have iOS or Android phone, and is unable to operate an AION provided smartphone device. * Subjects who are not willing to take an oral temperature per their care plan.
💊

What it tests

  • Remote Patient Monitoring
📍

Where

1 site
Ellis Hospital
Schenectady, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy